ArticleScientific reports2026
Effect of eight weeks of interval training on insulin signaling and neurodegeneration in the hippocampus of Methamphetamine-treated rats.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the effect of eight weeks of interval training on insulin signaling and neurodegeneration in the hippocampus of methamphetamine (METH)-treated rats. Thirty-two male Wistar rats were randomly divided into four equal groups (n = 8): saline, METH-1 (21-days of injection period), METH-2 (21-day injection period, followed by 8-week withdrawal), and METH+moderate-intensity interval training (MIT). Methamphetamine was injected intraperitoneally at 5 mg/kg per day for a period of 21 consecutive days. MIT was conducted on a treadmill at 60–65% of maximum speed, 5 days weekly for 8 weeks. At the end of the injection and training period, the hippocampal tissue of rats was extracted to evaluate the pathological changes and gene expression of related indicators. METH injection caused a disturbance in the insulin signaling pathway, resulting in increased neurodegeneration, as evidenced by a decrease in the expression of IRS-1 (p < 0.001) and Akt (p < 0.001) genes as well as an increase in the expression of GSK-3β (p < 0.001), APP (p = 0.007), tau (p = 0.006), p-tau (p < 0.001), and Caspases-3 (p = 0.003) genes. However, MIT significantly upregulated the expression of IRS-1 (p < 0.001) and Akt (p = 0.002), while downregulating APP (p = 0.028) and p-tau (p < 0.001). These findings suggest that MIT enhances insulin signaling activity and improves anxiety-like behaviors, thereby counteracting the detrimental effects of METH. Further studies are required to expand and validate these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.